Search research articles
Contact Us
Filters
Showing results (351-360 of 424) with videos related to
Page
of 43
Sort By:
Cancer Treatment Reports
|
August 1, 1977
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents
D D Von Hoff, M Rozencweig, W T Soper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1984
Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine
L J Laubenstein, R L Krigel, C M Odajnyk, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study
S M Grunberg, J J Crowley, R B Livingston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 18, 2013
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups
T Safra, W C Lai, L Borgato, et al.
The Oncologist
|
November 2, 2014
Chronic thalidomide and chemoembolization for hepatocellular carcinoma
Jennifer Wu, Jennifer Ng, Paul J Christos, et al.
Journal of the National Cancer Institute
|
October 16, 1996
Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexol
F M Muggia, T W Synold, E M Newman, et al.
Annals of Internal Medicine
|
November 1, 1979
Risk factors for doxorubicin-induced congestive heart failure
D D Von Hoff, M W Layard, P Basa, et al.
The American Journal of Medicine
|
April 1, 1985
Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast
J L Speyer, M D Green, N Dubin, et al.
Journal of the National Cancer Institute
|
July 21, 1993
Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis
M S Ray, F M Muggia, C G Leichman, et al.
Cancer Treatment Reports
|
December 1, 1984
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study
M Levin, K J Pandya, J D Khandekar, et al.
Page
of 43
Search research articles
Search
Showing results (351-360 of 424) with videos related to
Sort By:
Page
of 43
Cancer Treatment Reports
|
August 1, 1977
Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents
D D Von Hoff, M Rozencweig, W T Soper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1984
Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine
L J Laubenstein, R L Krigel, C M Odajnyk, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1991
Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study
S M Grunberg, J J Crowley, R B Livingston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 18, 2013
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups
T Safra, W C Lai, L Borgato, et al.
The Oncologist
|
November 2, 2014
Chronic thalidomide and chemoembolization for hepatocellular carcinoma
Jennifer Wu, Jennifer Ng, Paul J Christos, et al.
Journal of the National Cancer Institute
|
October 16, 1996
Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexol
F M Muggia, T W Synold, E M Newman, et al.
Annals of Internal Medicine
|
November 1, 1979
Risk factors for doxorubicin-induced congestive heart failure
D D Von Hoff, M W Layard, P Basa, et al.
The American Journal of Medicine
|
April 1, 1985
Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast
J L Speyer, M D Green, N Dubin, et al.
Journal of the National Cancer Institute
|
July 21, 1993
Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis
M S Ray, F M Muggia, C G Leichman, et al.
Cancer Treatment Reports
|
December 1, 1984
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study
M Levin, K J Pandya, J D Khandekar, et al.
Page
of 43